Group One Trading, L.P. I Bio, Inc. Transaction History

Group One Trading, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$0.23 - $160.0 $12,397 - $8.62 Million	53,900 Added 25.65%	264,033 $45,000
Q2 2022 Aug 11, 2022	BUY	$0.23 - $0.46 $4,398 - $8,797	19,126 Added 10.01%	210,133 $55,000
Q1 2022 May 12, 2022	SELL	$0.3 - $0.61 $7,504 - $15,259	-25,015 Reduced 11.58%	191,007 $82,000
Q4 2021 Feb 11, 2022	BUY	$0.55 - $1.04 $53,757 - $101,650	97,741 Added 82.63%	216,022 $119,000
Q3 2021 Nov 12, 2021	BUY	$1.06 - $1.52 $94,436 - $135,418	89,091 Added 305.21%	118,281 $125,000
Q2 2021 Aug 10, 2021	SELL	$1.22 - $1.65 $28,799 - $38,949	-23,606 Reduced 44.71%	29,190 $44,000
Q1 2021 May 12, 2021	BUY	$1.18 - $2.62 $28,515 - $63,314	24,166 Added 84.41%	52,796 $81,000
Q4 2020 Feb 10, 2021	SELL	$1.05 - $2.24 $14,874 - $31,731	-14,166 Reduced 33.1%	28,630 $30,000
Q3 2020 Nov 12, 2020	BUY	$1.7 - $6.41 $72,753 - $274,322	42,796 New	42,796 $87,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $23.8M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.